Pemetrexed and Gemcitabine as Combination Therapy for the Treatment of Group3 Medulloblastoma-Reference-Cited by-同舟云学术

Pemetrexed and Gemcitabine as Combination Therapy for the Treatment of Group3 Medulloblastoma

Published:2014-04 Issue:4 Volume:25 Page:516-529
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Morfouace Marie,Shelat Anang,Jacus Megan,Freeman Burgess B.,Turner David,Robinson Sarah,Zindy Frederique,Wang Yong-Dong,Finkelstein David,Ayrault Olivier,Bihannic Laure,Puget Stephanie,Li Xiao-Nan,Olson James M.,Robinson Giles W.,Guy R. Kiplin,Stewart Clinton F.,Gajjar Amar,Roussel Martine F.

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference45 articles.

1. Preclinical and clinical studies with combinations of pemetrexed and gemcitabine;Adjei;Semin. Oncol.,2002

2. Pemetrexed (ALIMTA), a novel multitargeted antineoplastic agent;Adjei;Clin. Cancer Res.,2004

3. An integrated in vitro and in vivo high-throughput screen identifies treatment leads for ependymoma;Atkinson;Cancer Cell,2011

4. Upfront association of carboplatin plus pemetrexed in patients with brain metastases of lung adenocarcinoma;Bailon;Neuro-oncol.,2012

5. Plasma and cerebrospinal fluid pharmacokinetics of 5-Aza-2′-deoxycytidine in rabbits and dogs;Chabot;Cancer Res.,1983

Cited by 127 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CTPS1 inhibition synergizes with replication stress signaling inhibition inMYC-amplified Group 3 medulloblastoma;2024-06-04

2. Development of a high-throughput screening platform to identify new therapeutic agents for Medulloblastoma Group 3;SLAS Discovery;2024-03

3. Evolution of Systemic Therapy in Medulloblastoma Including Irradiation-Sparing Approaches;Diagnostics;2023-12-16

4. Molecular and functional profiling of chemotolerant cells unveils nucleoside metabolism-dependent vulnerabilities in medulloblastoma;Acta Neuropathologica Communications;2023-11-17

5. Cross-species analysis of SHH medulloblastoma models reveals significant inhibitory effects of trametinib on tumor progression;Cell Death Discovery;2023-09-19